查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1988167

血液处理用抛弃式产品市场：2026-2032年全球市场预测（依产品类型、血液成分、材料、应用、最终用户和销售管道）

Blood Processing Disposables Market by Product Type, Blood Component, Material, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年血液处理用抛弃式产品的市值为 140 亿美元，预计到 2026 年将成长至 154.4 亿美元，年复合成长率为 11.15%，到 2032 年将达到 293.6 亿美元。

主要市场统计数据
基准年 2025 140亿美元
预计年份：2026年 154.4亿美元
预测年份 2032 293.6亿美元
复合年增长率 (%) 11.15%

对影响各种医疗保健机构中一次性血液处理抛弃式产品的临床、监管和供应链趋势进行权威分析。

抛弃式产品的市场取决于三个因素：临床需求、生产精度和监管。血袋、离心机套件、采血器、过滤系统和输血器等设备对于包括血液采集、分离和输血在内的各种临床流程至关重要。最终，这些产品构成了血库、诊断检查室和医院所提供服务的基础，形成了一个相互关联的生态系统，其中高可靠性和可追溯性至关重要。

临床自动化、材料创新、监管可追溯性和永续性压力都在重塑一次性产品的市场格局和供应商策略。

近年来，临床环境、供应链结构和创新模式都发生了变革性变化，这些变化共同重塑了抛弃式产品的市场格局。首先，在临床工作流程中，自动化和封闭式系统设计对于降低污染风险和简化劳动密集任务至关重要。自动化离心机套件和自动化分离技术因其能够标准化输出并提高处理能力而备受关注。其次，从先进聚合物到改良阻隔膜，材料的创新使得产品具有更长的储存稳定性和更高的生物相容性，为低温运输管理和易损成分的长期储存创造了新的可能性。

2025 年新的关税趋势将迫使一次性产品和分销管道整体的成本重新分配、区域製造地的转移以及采购来源的多元化。

2025年关税表的实施和贸易政策的调整，为在美国营运或从美国采购的製造商、经销商和采购团队带来了许多复杂挑战。关税变化会影响整个产品系列的接收成本，包括初级和卫星血袋、自动和手动离心机套件、作为配件或完整套装的采血器、过滤装置（例如白血球去除过滤器和病原体去除过滤器）以及各种运输套装（从定制规格到标准规格）。由于直销和第三方经销商面临的利润率敏感度和合约限制各不相同，这些成本压力对不同市场通路的影响也各不相同。

细分市场分析揭示了产品差异、临床应用、最终用户、组件特定处理、材料和销售管道如何决定商业性和监管重点。

精细化的细分方法揭示了各个维度（包括产品、应用、最终用户、血液成分、材料和销售管道）的价值来源和营运需求的差异。在产品层面，血袋及其主要和辅助组件与提供自动化和手动两种形式的离心机套件有所区别。同时，采血套装涵盖从配件到完整解决方案的各种类型，过滤系统在白血球去除和病原体去除能力方面存在差异，而输血套装则从定制解决方案到标准化产品，种类繁多。基于应用的细分区分了采血工作流程和分离/输血工作流程，其中分离过程本身又分为自动化和手动两种，对设备、人员配备和品管的影响各不相同。

临床应用率、监管复杂性和生产重点方面的区域差异，使得打入市场策略必须针对每个地区量身定制：美洲、欧洲、中东和非洲以及亚太地区。

区域趋势对美洲、欧洲、中东和非洲（EMEA）以及亚太地区的创新采纳、监管时间表和采购行为有显着影响。在美洲，集中式血库网路和一体化医院系统推动了对扩充性、高通量一次性系统的需求，促使供应商投资快速物流和本土合格。同时，在欧洲、中东和非洲，不同的管理体制和采购模式使得遵守不同的标准、标籤本地化以及与当地分销商伙伴关係对于市场准入和可持续分销至关重要。

在竞争激烈的环境中，能够证明可靠性和临床价值以及区域灵活性的整合解决方案供应商、技术专家和製造商具有竞争优势。

抛弃式产品市场的竞争格局由三个部分组成：既有产品系列丰富的成熟全球企业，也有专注于先进过滤和自动化分离技术的利基製造商，还有利用本地生产和分销网络的区域性企业。主要企业致力于提供整合解决方案，将抛弃式产品与相容设备、品管系统和服务交付相结合，从而加强与客户的关係。同时，一些专业公司则透过专有的过滤材料、先进的聚合物配方或一次性自动化模组来应对特定的临床挑战，例如提高白血球去除效率和病原体减少，从而实现差异化竞争。

为领导企业提供切实可行的策略步骤，以协调产品模组化、采购弹性、自动化、通路平衡和永续性，从而确保竞争优势。

产业领导企业应采取多管齐下的策略，将产品开发、供应链韧性和商业性执行与不断变化的临床需求和产业实际情况相协调。优先考虑模组化和扩充性的产品设计至关重要，这将有助于在主过滤袋和卫星采血袋、自动和手动离心机套件、配件、全套采血设备以及白血球和病原体去除过滤装置之间快速配置变更。这种设计柔软性可缩短针对不同地区的产品上市时间，并提高对临床医师回馈的应对力。

透过结合技术审查和相关人员访谈的透明混合方法，利用稳健的三角测量法检验营运和商业见解。

本研究途径结合了对技术文献、监管申报文件和公开临床指南的系统性回顾，以及定性的一手调查，以检验营运和商业方面的见解。二手研究着重于与血袋、离心机套件、采集器、过滤系统和输血器相关的设备规格、材料特性和标准指南，以及影响血液采集、分离和输血流程的政策。为补充这些内容，一手调查计画还包括对血库高级采购人员、检查室经理、负责输血服务的临床医生以及生产和销售公司的管理人员进行访谈，以了解他们对挑战和推广应用驱动因素的第一手观点。

概述产品差异化、采购弹性、监管合规性和区域重点如何将技术进步转化为临床和营运价值。

总之，抛弃式产品产业正处于一个转折点，临床对安全性和效率的需求与供应链压力以及不断变化的监管预期交织在一起。血袋、离心机套件、采血器、过滤装置和输血器等产品层面的差异化将越来越受到重视，其价值体现在自动化能力、材料性能以及区域市场准入等方面。从血库到诊断检查室和医院，终端用户将优先选择那些能够显着降低污染风险、提高处理效率并确保即使在关税和物流条件波动的情况下也能可靠供应的供应商。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：血液处理用抛弃式产品市场：依产品类型划分

  • 血袋
    • 主要包
    • 卫星套件
  • 离心分离试剂盒
    • 自动套件
    • 手册套件
  • 采血工具包
    • 配件套装
    • 全套
  • 过滤装置
    • 白血球去除过滤器
    • 病原体去除过滤器
  • 传输组
    • 自订套装
    • 标准集

第九章 血液处理用抛弃式产品市场：依血液成分划分

  • 电浆
    • 冷冻机配方
    • 新鲜冷冻血浆
  • 血小板
  • 红血球
  • 全血

第十章：血液处理用抛弃式产品市场：依材料分类

  • 聚丙烯
  • PVC
  • 硅酮

第十一章 血液处理用抛弃式产品市场：依应用领域划分

  • 血液样本
  • 分离
    • 自动分离
    • 人工分离
  • 输血

第十二章 血液处理用抛弃式产品市场：依最终用户划分

  • 血库
  • 诊断检查室
  • 医院

第十三章：血液处理抛弃式产品市场：依销售管道划分

  • 直销
  • 销售代理

第十四章 血液处理用抛弃式产品市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：血液处理用抛弃式产品市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 血液处理用抛弃式产品市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 美国：血液处理用抛弃式产品的市场

第十八章 中国：血液处理抛弃式产品市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Abbott Laboratories
  • Advin Health Care
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BIO-X
  • Cardinal Health, Inc.
  • Fresenius Kabi AG
  • GE HealthCare Technologies Inc.
  • Grifols, SA
  • Haemonetics Corporation
  • Kawasumi Laboratories, Inc.
  • Labtech Disposables
  • Maco Pharma SAS
  • Medtronic plc
  • Merck KGaA
  • Narang Medical Limited
  • Qiagen NV
  • SARSTEDT AG & Co.
  • Siemens Healthineers AG
  • TERUMO BCT, INC.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-F97DD5A7E121

The Blood Processing Disposables Market was valued at USD 14.00 billion in 2025 and is projected to grow to USD 15.44 billion in 2026, with a CAGR of 11.15%, reaching USD 29.36 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.00 billion
Estimated Year [2026] USD 15.44 billion
Forecast Year [2032] USD 29.36 billion
CAGR (%) 11.15%

An authoritative framing of clinical, regulatory, and supply chain dynamics that shape blood processing disposables across care settings

The blood processing disposables landscape sits at the intersection of clinical necessity, manufacturing precision, and regulatory scrutiny. Devices such as blood bags, centrifugation kits, collection sets, filtration devices, and transfer sets are integral to a wide spectrum of clinical pathways including collection, separation, and transfusion. In turn, these products underpin services delivered by blood banks, diagnostic laboratories, and hospitals, creating an interconnected ecosystem that demands high reliability and traceability.

Technological advances, evolving clinical protocols, and materials science improvements have steadily raised performance and safety standards. Simultaneously, supply chain dynamics and regulatory expectations have imposed new layers of complexity for manufacturers and procurement teams. Given the critical nature of blood handling, even incremental gains in device safety, handling ergonomics, or sterilization assurance translate into meaningful clinical and operational improvements. This introduction frames the fundamental dynamics that the subsequent sections unpack in greater technical and commercial detail.

Converging clinical automation, materials innovation, regulatory traceability, and sustainability pressures are reshaping the disposables landscape and supplier strategies

The last several years have witnessed transformative shifts across clinical practice, supply chain architecture, and innovation models that collectively redefine the blood processing disposables market. First, clinical workflows increasingly prioritize automation and closed-system designs to reduce contamination risk and streamline labor-intensive tasks; automated centrifugation kits and automated separation techniques are gaining attention for their capacity to standardize outputs and improve throughput. Second, materials innovation - from advanced polymers to improved barrier films - has enabled devices with longer shelf stability and enhanced biocompatibility, creating new possibilities for cold chain management and extended storage of sensitive components.

Concurrently, procurement strategies have evolved toward supplier consolidation and vendor-managed inventory to mitigate disruption risk and control cost. Regulatory authorities have raised expectations for post-market surveillance and traceability, prompting manufacturers to embed serialization and data capture capabilities into disposables. Finally, sustainability considerations are nudging design choices toward recyclable or lower-impact materials and processes, while also driving interest in devices that minimize waste through multi-functionality or modularity. Together, these shifts are realigning competitive positioning, investment priorities, and adoption timelines across the ecosystem.

New 2025 tariff dynamics are forcing cost reallocation, regional manufacturing shifts, and sourcing diversification across the full disposables product and channel spectrum

The introduction of updated tariff schedules and trade policy adjustments in 2025 has introduced tangible complexity for manufacturers, distributors, and procurement teams operating in or sourcing from the United States. Tariff changes affect landed costs across the product portfolio - blood bags including primary and satellite variants, centrifugation kits both automated and manual, collection sets whether accessory or complete, filtration devices such as leukocyte reduction and pathogen reduction filters, and transfer sets that range from custom to standard configurations. These cost pressures cascade differently depending on the route to market, as direct sales operations and third-party distributors each face distinct margin sensitivities and contractual constraints.

In response, supply chain managers and commercial leaders are recalibrating sourcing strategies, exploring regionalization of production, and negotiating longer-term contracts to stabilize input cost exposure. Some manufacturers are accelerating qualification of alternate suppliers for key materials like polypropylene, PVC, and silicone to diversify risk, while others are revisiting transfer pricing, inventory buffers, and logistics routing to optimize total landed costs. The tariff environment also amplifies the value of localized manufacturing capacity in the Americas and in other strategic regions, since proximity can reduce the tariff burden and improve service levels for end users such as blood banks, diagnostic laboratories, and hospitals. Ultimately, the interplay between tariffs, product complexity, and channel structure will determine which players can preserve competitiveness and which will need to adapt commercial models to maintain access to the US market.

Segment-level insights reveal how product variants, clinical applications, end users, component-specific handling, materials, and sales channels determine commercial and regulatory priorities

A nuanced segmentation approach reveals differentiated value drivers and operational requirements across product, application, end-user, blood component, material, and sales channel dimensions. Product-level distinctions separate Blood Bags and their primary and satellite configurations from Centrifugation Kits offered in automated and manual formats, while Collection Sets span accessory and complete solutions; Filtration Devices vary between leukocyte reduction and pathogen reduction capabilities, and Transfer Sets range from custom-engineered solutions to standardized offerings. Application segmentation distinguishes Collection from Separation and Transfusion workflows, with Separation itself bifurcated into automated and manual processes that have divergent equipment, staffing, and quality control implications.

End users include Blood Banks that emphasize throughput, traceability, and long-term storage compatibility; Diagnostic Laboratories that prioritize specimen integrity, chain-of-custody, and throughput for testing workflows; and Hospitals that require reliable, on-demand disposables for both routine and emergency transfusion pathways. Blood Component segmentation highlights plasma offerings such as cryoprecipitate and fresh frozen plasma, platelets, red blood cells, and whole blood, each with unique handling, filtration, and storage demands that influence product design and validation. Material choices - polypropylene, PVC, and silicone - drive compatibility with sterilization methods, shelf life, and regulatory filing strategies, while sales channels split between Direct and Distributor routes, shaping service models, contract terms, and post-sale support obligations. When viewed collectively, this segmentation underscores that product development, regulatory strategy, and commercial execution must be aligned to the specific clinical and operational contexts of target customers.

Regional variation in clinical adoption, regulatory complexity, and manufacturing priorities requires tailored market access strategies across the Americas, EMEA, and Asia-Pacific

Regional dynamics exert strong influence on innovation adoption, regulatory timelines, and procurement behavior across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In the Americas, centralized blood bank networks and integrated hospital systems create demand for scalable, high-throughput disposable systems and incentivize suppliers to invest in quick-response logistics and domestic qualification. Conversely, Europe, the Middle East & Africa presents a mosaic of regulatory regimes and procurement models where conformity to diverse standards, localization of labeling, and regional distributor partnerships are critical to market access and sustained uptake.

Asia-Pacific is characterized by rapid capacity expansion, heterogeneous clinical infrastructure, and an accelerating push toward automation in higher-volume centers, which together create opportunities for both global incumbents and regional manufacturers. Transitioning between these regional realities requires suppliers to balance global product platforms with configurable localization, invest in region-specific clinical validation, and cultivate distributor or hospital system relationships that can bridge regulatory and logistical barriers. Moreover, cross-border trade considerations, tariff regimes, and local manufacturing incentives will continue to shape where and how suppliers prioritize capital allocation and commercial focus.

Competitive dynamics reward integrated solution providers, technical specialists, and regionally agile manufacturers that demonstrate reliability and clinical value

Competitive dynamics in the blood processing disposables sector are defined by a mix of global incumbents with broad product portfolios, specialized niche manufacturers focused on advanced filtration or automated separation technologies, and regional players who leverage localized production and distributor networks. Leading organizations emphasize integrated solutions that combine disposables with compatible instrumentation, quality management systems, and service offerings to lock in account-level relationships. Meanwhile, specialist firms differentiate through proprietary filtration media, advanced polymer formulations, or single-use automation modules that address specific clinical pain points such as leukocyte reduction efficiency or pathogen mitigation.

Strategic partnerships and M&A remain common approaches for scaling capabilities, accelerating market entry into new geographies, or complementing product portfolios with adjacent technologies. Companies that excel at regulatory harmonization, robust post-market surveillance, and rapid field support secure preferential status with high-volume blood banks and hospital systems. Additionally, investments in manufacturing flexibility, including configurable transfer sets and customizable collection set assemblies, allow suppliers to respond quickly to clinician preferences and procurement tenders. Collectively, the competitive landscape rewards technical differentiation, supply reliability, and the ability to demonstrate measurable clinical and operational benefits to end users.

Practical strategic steps for leaders to align product modularity, sourcing resilience, automation, channel balance, and sustainability to secure competitive advantage

Industry leaders should adopt a multi-dimensional strategy that aligns product development, supply chain resilience, and commercial execution with evolving clinical needs and trade realities. First, prioritize modular and scalable product designs that allow for rapid configuration between primary and satellite blood bags, automated and manual centrifugation kits, accessory and complete collection sets, and both leukocyte reduction and pathogen reduction filtration devices. This design flexibility reduces time-to-market for localized variants and improves responsiveness to clinician feedback.

Second, diversify material sourcing for critical polymers such as polypropylene, PVC, and silicone, and qualify alternate suppliers across multiple regions to reduce exposure to tariff-driven cost volatility. Third, invest in automation and closed-system workflows that support both automated and manual separation use cases, enabling end users to standardize procedures and improve traceability. Fourth, strengthen distributor relationships in complex regulatory regions while maintaining direct sales capabilities in high-volume systems to balance margin, control, and service requirements. Finally, incorporate sustainability targets into product roadmaps and packaging strategies to meet procurement criteria and public-sector tender priorities, while documenting lifecycle impacts to support procurement decisions.

A transparent mixed-methods research process combining technical review and stakeholder interviews to validate operational and commercial insights with robust triangulation

The research approach combined a structured review of technical literature, regulatory filings, and publicly available clinical guidance with qualitative primary research to validate operational and commercial insights. Secondary analysis focused on device specifications, material property data, and standards guidance relevant to blood bags, centrifugation kits, collection sets, filtration devices, and transfer sets, as well as policies that affect collection, separation, and transfusion workflows. To complement this, the primary research program included interviews with senior procurement leaders from blood banks, laboratory managers, clinicians overseeing transfusion services, and executives from manufacturer and distributor organizations to surface first-hand perspectives on pain points and adoption drivers.

Data validation employed triangulation across sources, cross-referencing product claims with regulatory summaries and clinician feedback to ensure practical relevance. Where possible, lifecycle and materials compatibility discussions were corroborated through technical white papers and manufacturer technical dossiers. The methodology emphasized transparency in assumptions, traceability of qualitative inputs, and iterative validation of emerging themes, ensuring that the conclusions reflect grounded, actionable observations rather than speculative projections.

Concluding synthesis of how product differentiation, sourcing resilience, regulatory alignment, and regional focus convert technical advances into clinical and operational value

In conclusion, the blood processing disposables domain is at an inflection point where clinical demand for safety and efficiency intersects with supply chain pressures and evolving regulatory expectations. Product-level differentiation across blood bags, centrifugation kits, collection sets, filtration devices, and transfer sets will increasingly be interpreted through the lenses of automation capability, materials performance, and regional market access. End users from blood banks to diagnostic laboratories and hospitals will favor suppliers that can demonstrably reduce contamination risk, improve handling ergonomics, and ensure reliable availability under shifting tariff and logistics conditions.

Forward-looking organizations that integrate design modularity, diversified sourcing, and strong post-market support will find themselves better positioned to capture operational partnerships with high-volume centers. At the same time, the ability to localize production and adapt to region-specific regulatory and procurement nuances will determine market entry success across the Americas, Europe, Middle East & Africa, and Asia-Pacific. These coordinated efforts will enable stakeholders to convert technical advancements into measurable clinical and operational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Processing Disposables Market, by Product Type

  • 8.1. Blood Bags
    • 8.1.1. Primary Bags
    • 8.1.2. Satellite Bags
  • 8.2. Centrifugation Kits
    • 8.2.1. Automated Kits
    • 8.2.2. Manual Kits
  • 8.3. Collection Sets
    • 8.3.1. Accessory Sets
    • 8.3.2. Complete Sets
  • 8.4. Filtration Devices
    • 8.4.1. Leukocyte Reduction Filter
    • 8.4.2. Pathogen Reduction Filter
  • 8.5. Transfer Sets
    • 8.5.1. Custom Sets
    • 8.5.2. Standard Sets

9. Blood Processing Disposables Market, by Blood Component

  • 9.1. Plasma
    • 9.1.1. Cryoprecipitate
    • 9.1.2. Fresh Frozen Plasma
  • 9.2. Platelet
  • 9.3. Red Blood Cell
  • 9.4. Whole Blood

10. Blood Processing Disposables Market, by Material

  • 10.1. Polypropylene
  • 10.2. PVC
  • 10.3. Silicone

11. Blood Processing Disposables Market, by Application

  • 11.1. Collection
  • 11.2. Separation
    • 11.2.1. Automated Separation
    • 11.2.2. Manual Separation
  • 11.3. Transfusion

12. Blood Processing Disposables Market, by End User

  • 12.1. Blood Bank
  • 12.2. Diagnostic Laboratory
  • 12.3. Hospital

13. Blood Processing Disposables Market, by Sales Channel

  • 13.1. Direct
  • 13.2. Distributor

14. Blood Processing Disposables Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Blood Processing Disposables Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Blood Processing Disposables Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Blood Processing Disposables Market

18. China Blood Processing Disposables Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Abbott Laboratories
  • 19.7. Advin Health Care
  • 19.8. Beckman Coulter, Inc.
  • 19.9. Becton, Dickinson and Company
  • 19.10. Bio-Rad Laboratories, Inc.
  • 19.11. BIO-X
  • 19.12. Cardinal Health, Inc.
  • 19.13. Fresenius Kabi AG
  • 19.14. GE HealthCare Technologies Inc.
  • 19.15. Grifols, S.A.
  • 19.16. Haemonetics Corporation
  • 19.17. Kawasumi Laboratories, Inc.
  • 19.18. Labtech Disposables
  • 19.19. Maco Pharma SAS
  • 19.20. Medtronic plc
  • 19.21. Merck KGaA
  • 19.22. Narang Medical Limited
  • 19.23. Qiagen N.V.
  • 19.24. SARSTEDT AG & Co.
  • 19.25. Siemens Healthineers AG
  • 19.26. TERUMO BCT, INC.
  • 19.27. Terumo Corporation
  • 19.28. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 249. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 251. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 253. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 254. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 255. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 257. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 290. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 291. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 292. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 293. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 294. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 295. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 296. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 297. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 299. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. NATO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. NATO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. NATO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2032 (USD MILLION)
  • TABLE 305. NATO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2032 (USD MILLION)
  • TABLE 306. NATO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 307. NATO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2032 (USD MILLION)
  • TABLE 308. NATO